Related Experiment Video

Updated: Aug 6, 2026

Measuring Neuromuscular Junction Functionality
10:40

Measuring Neuromuscular Junction Functionality

Published on: August 6, 2017

[Increase in mortality for motor neuron disease in Italy, 1980-1999]

Pierluigi Altavista1, Stefano Belli, Alessandra Binazzi

  • 1Sezione di tossicologia e scienze biomediche, ENEA (Casaccia), Roma.

Epidemiologia E Prevenzione
|August 17, 2006
PubMed
Abstract

Insights

Motor neuron disease (MND) mortality rates in Italy increased significantly between 1980-1999, particularly in females. This rise in MND deaths may be linked to aging populations, improved diagnostics, and environmental factors.

Area of Science:

  • Epidemiology
  • Neurology
  • Public Health

Background:

  • Motor neuron disease (MND) is a progressive neurodegenerative condition with significant mortality.
  • Understanding geographical and temporal trends in MND mortality is crucial for public health planning and research.

Purpose of the Study:

  • To analyze national and sub-national mortality rates for motor neuron disease (MND) in Italy from 1980 to 1999.
  • To identify trends and geographical variations in MND mortality across Northern, Central, and Southern Italy.

Main Methods:

  • Mortality data for MND (ICD code 335.2) were obtained from the Italian National Institute for Statistics (ISTAT).
  • Age-standardized mortality rates were calculated for 5-year periods (1980-1999) using the 1991 Italian population structure.
  • Sex and age-specific mortality rates were analyzed for two decades (1980-1989 and 1990-1999).

Main Results:

  • The annual age-standardized mortality rate for MND in Italy (1980-1999) was 1.35 per 100,000 for males and 1.10 per 100,000 for females.
  • From 1980-84 to 1995-99, national MND mortality rates increased by 39.3% in males and 78.2% in females.
  • Sub-area increases varied, with Southern Italy showing the largest female mortality rate increase (114.3%) in the same period.

Conclusions:

  • The observed increase in MND mortality is likely multifactorial.
  • Contributing factors may include population aging, improved diagnostic accuracy, and potentially environmental risk factors (e.g., metals, solvents, pesticides) and lifestyle changes (e.g., smoking, diet, professional sports).
  • Further research into these factors is warranted to understand and potentially mitigate MND mortality trends.

More Related Videos

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

Related Concept Videos

Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...